Microba Overview
- Year Founded
-
2017
- Status
-
Public
- Employees
-
80
- Stock Symbol
-
MAP
- Investments
-
1
- Share Price
-
$0.02
- (As of Friday Closing)
Microba General Information
Description
Microba Life Sciences Ltd is a commercial-stage company with technology for measuring the human gut microbiome and engages in providing gut microbiome testing services globally to consumers, clinicians, and researchers. It is also involved in developing new pathology services, therapeutics, and diagnostics based on the human gut microbiome. The company's operating segments are Testing Services and Supplements, which derive key revenue, and Research and Development. Geographically, the company derives maximum revenue from Australia and the rest from Europe, New Zealand, the United States, Asia, and other regions.
Contact Information
Website
www.microba.comCorporate Office
- Level 10
- 324 Queen Street
- Brisbane, Queensland 4000
- Australia
Corporate Office
- Level 10
- 324 Queen Street
- Brisbane, Queensland 4000
- Australia
Microba Timeline
Microba Stock Performance
As of 13-Nov-2026, Microba’s stock price is $0.02. Its current market cap is $18.2M with 743M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.02 | $0.02 | $0.02 - $0.07 | $18.2M | 743M | 340K |
Microba Financials Summary
As of 30-Sep-2026, Microba has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2026 30-Jun-2026 | FY 2025 30-Jun-2025 | FY 2024 30-Jun-2024 |
|---|---|---|---|---|
| EV | 21,871 | 11,339 | 19,457 | 29,916 |
| Revenue | 9,998 | 10,138 | 7,923 | |
| EBITDA | (11,279) | (7,131) | (11,832) | |
| Net Income | (14,037) | (9,666) | (13,066) | |
| Total Assets | 27,396 | 30,985 | 38,794 | |
| Total Debt | 2,825 | 2,110 | 1,057 |
Microba Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Microba Comparisons
Industry
Financing
Details
Microba Competitors (26)
One of Microba’s 26 competitors is MeiraGTx, a Formerly VC-backed company based in New York, NY.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| MeiraGTx | Formerly VC-backed | New York, NY | ||||
| PureTech Health | Formerly VC-backed | Boston, MA | ||||
| Bicycle Therapeutics | Formerly VC-backed | Cambridge, United Kingdom | ||||
| Agenus | Formerly VC-backed | Lexington, MA | ||||
| Caris Life Sciences | Formerly PE-Backed | Irving, TX |
Microba Patents
Microba Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2018903135-A0 | Microbial community profiling method | Inactive | 24-Aug-2018 | ||
| AU-2018903134-A0 | Profiling method and system | Inactive | 24-Aug-2018 | ||
| AU-2018902147-A0 | Characterisation method | Inactive | 15-Jun-2018 | ||
| WO-2019237158-A1 | Methods for sample preparation and microbiome characterisation | Inactive | 15-Jun-2018 | C12Q1/24 |
Microba Signals
Microba Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Microba Acquisitions (1)
Microba’s most recent deal was a Merger/Acquisition with Invivo Healthcare for . The deal was made on 05-Dec-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Invivo Healthcare | 05-Dec-2023 | Merger/Acquisition | Biotechnology |
Microba ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
Microba Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Invivo Healthcare | Stroud, United Kingdom | 2007 |
Microba FAQs
-
When was Microba founded?
Microba was founded in 2017.
-
Where is Microba headquartered?
Microba is headquartered in Brisbane, Australia.
-
What is the size of Microba?
Microba has 80 total employees.
-
What industry is Microba in?
Microba’s primary industry is Laboratory Services (Healthcare).
-
Is Microba a private or public company?
Microba is a Public company.
-
What is Microba’s stock symbol?
The ticker symbol for Microba is MAP.
-
What is the current stock price of Microba?
As of 13-Nov-2026 the stock price of Microba is $0.02.
-
What is the current market cap of Microba?
The current market capitalization of Microba is $18.2M.
-
Who are Microba’s competitors?
MeiraGTx, PureTech Health, Bicycle Therapeutics, Agenus, and Caris Life Sciences are some of the 26 competitors of Microba.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process